SEC Filing Details

SEC Filing Details

Document Details

Form
POS AM
Filing Date
Jun 22, 2021
Document Date
Jun 22, 2021
Form Description
Post-effective amendment to an S-Type filing
Filing Group
Registration Statements
Company
ReShape Lifesciences
Issuer
For investor inquiries, please contact:

ReShape Lifesciences Investor Contact:
Thomas Stankovich
Chief Financial Officer
949-276-6042
ir@ReShapeLifesci.com

Investor Contacts:
Rx Communications Group
Michael Miller
917-633-6086
mmiller@rxir.com

PRINT PAGE

EMAIL PAGE